Warning against New Nicotine Product Infiltrating Schools in New Zealand

Regulations by 2FIRSTS.ai
Apr.17.2024
Warning against New Nicotine Product Infiltrating Schools in New Zealand
New Zealand health professionals warn about the growing presence of ZYN nicotine pouches in schools, posing addiction risks.

According to a report from The New Zealand Herald on April 17th, health professionals in New Zealand are issuing warnings about a new type of nicotine product that is infiltrating schools in New Zealand. ZYN is a brand of smokeless nicotine pouches that is gradually becoming mainstream through social media influencers on platforms such as TikTok and Instagram.

 

This product, based in Sweden, aims to be a replacement for smoking or e-cigarettes to help users quit nicotine.

 

Richard Edwards, professor at the University of Otago and co-director of Aspire2025, expressed concern to the Pioneer Press about the widespread acceptance of these products among young people.

 

While these products may not be as harmful as smoking, they may still be just as addictive, leading to widespread use among young people and creating a widespread dependency on nicotine.

 

Edwards warned that unlike other nicotine pouch brands such as Snus, ZYN brand does not contain tobacco. These nicotine pouches resemble small tea bags and are placed between the lip and gum. They are typically sold in brightly colored cans of 15 to 20, and come in various flavors including berry, coffee, and citrus.

 

New Zealand banned the sale of nicotine pouches in 2020, but importing them from overseas remains legal as long as they are not sold within the country. Despite the ban, The Pioneer newspaper has learned that these products are now making their way into schools nationwide, with reports of students selling them to their peers.

 

However, Sean Teddy, the head of operations and integration at the Ministry of Education, stated that the schools have not raised any concerns about this issue with the department.

 

He emphasized,

 

According to the revised Smoke-free Environments and Regulated Products (Vaping) Amendment Act 2020, smoking or using e-cigarettes on school grounds, kura kaupapa (Māori language schools), early childhood education centers, and kōhanga reo (Māori language immersion preschools) is illegal.

 

In an earlier statement, Deputy Health Minister Casey Costello hinted that she hopes to introduce oral nicotine products, including snus and chewing tobacco, to provide smokers with more and safer alternative smoking options.

 

However, Edwards believes that the introduction of oral nicotine products may not work as expected. Edwards is concerned that these oral nicotine products may not target the intended demographic. He said, "The biggest users of e-cigarettes are young people...we want 50-year-old smokers." He expressed that allowing these products to enter the market without restrictions could lead to more young people becoming dependent on nicotine.

 

Edwards believes that these products should not be introduced unless there are very strong reasons to do so. He suggests that a distribution model similar to that of pharmacies selling only prescription drugs could be implemented, thereby more strictly regulating distribution. However, if these products are widely available in locations such as convenience stores and gas stations, we may see another product being widely used among young people.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

How Large Is France’s Off-Channel Tobacco Market? Logista Says It Has Become Structural, While the Official Estimate Is 17.7% and Some Industry Studies Put It Above 50%
How Large Is France’s Off-Channel Tobacco Market? Logista Says It Has Become Structural, While the Official Estimate Is 17.7% and Some Industry Studies Put It Above 50%
Logista France says tobacco consumption outside France’s official tobacconist network has become a large and structural market phenomenon, but official and industry estimates differ sharply. France’s TAFE study estimates that 17.7% of tobacco consumption escaped domestic taxation in 2023, with most of that volume attributed to cross-border purchasing rather than street sales. Some industry studies use broader off-channel definitions and put the figure above 50%. Meanwhile, French Customs seized 547.94 tonnes of tobacco in 2025, up 12%, showing continued pressure from illicit trade.
Sep.04
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Former Roche Neuroscience and Rare Diseases Communications Director Ria Kioupritzi Joins PMI as Scientific Affairs Director
Eleftheria (Ria) Kioupritzi, a biopharmaceutical professional with more than 15 years of experience, has joined Philip Morris International as Director Scientific Affairs within Corporate Affairs. She previously served at Roche as Senior Scientific Communications Director for Neuroscience and Rare Diseases and worked extensively in spinal muscular atrophy. Her earlier career also covered competitive intelligence, clinical and regulatory monitoring, pipeline development and launch preparation. During her time working in Roche's SMA field, Evrysdi passed through several U.S. FDA milestones, including its initial approval, an expanded indication for younger infants and approval of a tablet formulation. Public records do not show that Kioupritzi herself led the FDA submissions.
Sep.22
Australian Coalition Unveils Illicit Tobacco Plan With 80% Excise Cut and Legal, Taxed Vapes and Nicotine Pouches
Australian Coalition Unveils Illicit Tobacco Plan With 80% Excise Cut and Legal, Taxed Vapes and Nicotine Pouches
Australia’s Coalition has unveiled a national illicit-tobacco policy that would cut tobacco excise by 80% and create legal, regulated and taxed adult markets for vaping products and nicotine pouches if it wins government. The plan proposes an excise of A$0.50 per millilitre of e-liquid and A$0.025 per milligram of nicotine in pouches, alongside A$200 million in additional enforcement and a A$60 million three-year public-awareness campaign. The Coalition says the package would narrow the price advantage of illicit products and undermine organised crime, while Labor and public-health groups warn that dramatically cheaper cigarettes could reverse long-term declines in smoking.
Sep.03
China STMA Deputy Administrator Meets KT&G COO as Heated Cigarette Rules Advance
China STMA Deputy Administrator Meets KT&G COO as Heated Cigarette Rules Advance
Wang Gongcheng, deputy administrator of China’s State Tobacco Monopoly Administration, met KT&G Chief Operating Officer Lee Sang-hak in Shanghai on September 1, according to Oriental Tobacco News. The meeting comes as China seeks public comment on a draft mandatory national standard for heated cigarettes. The report did not disclose the subjects discussed or indicate whether heated tobacco products or market access were addressed.
News
Sep.02
NAS 2026 | Former FDA Tobacco Chief Mitch Zeller Calls for Shift From “End Game” to “End State”
NAS 2026 | Former FDA Tobacco Chief Mitch Zeller Calls for Shift From “End Game” to “End State”
At the 2026 New Approaches Summit in New York, former FDA Center for Tobacco Products Director Mitch Zeller called for the tobacco harm reduction debate to shift from the traditional “end game” toward defining a desired “end state.” He also highlighted unresolved concerns around dual use, argued that biomarkers of exposure may be more meaningful than cigarettes-per-day in assessing risk reduction, and said nicotine misperceptions remain a major barrier to public health progress.
Sep.25
As JUUL2 Wins FDA Authorization, Harm Reduction Journal Highlights the Role of Real-World Evidence in Nicotine Product Regulation
As JUUL2 Wins FDA Authorization, Harm Reduction Journal Highlights the Role of Real-World Evidence in Nicotine Product Regulation
A commentary published in the international open-access, peer-reviewed Harm Reduction Journal argues that randomized controlled trials remain central to evaluating smoking cessation efficacy but cannot alone capture real-world uptake, complete switching, longer-term use and population impact of non-combustible nicotine products such as e-cigarettes, heated tobacco and nicotine pouches. The authors frame impact as “reach × efficacy” and call for real-world evidence to complement RCTs. Three days after publication, the FDA authorized three JUUL2 products and highlighted complete switching among adult smokers in explaining its decision, providing a timely regulatory backdrop to the debate.
Sep.08